Capsules used in dry powder inhalers (DPI) are, in many ways, different from those that are orally administered. From a regulatory perspective, capsules for inhalation must comply with the compendialrequirements for inhalation products, highlights Fr d rique Bordes-Picard, manager, PharmaceutiOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.